BioCentury | Nov 30, 2017
Translation in Brief

New Therapeutic Targets and Biomarkers: November 2017

...RAMA could be used to develop a malaria vaccine. Wellcome Trust Sanger Institute Distillery Therapeutics Plasmodium falciparum erythrocyte binding antigen-181...
BioCentury | Nov 28, 2017
Distillery Therapeutics

Infectious disease

...Institute, Cambridge, U.K. email: julian.rayner@sanger.ac.uk Mark Zipkin Wellcome Trust Sanger Institute Plasmodium falciparum cysteine-rich protective antigen (P. falciparum CyRPA) Plasmodium falciparum erythrocyte binding antigen-181...
Items per page:
1 - 2 of 2